Rare CD4 cytotoxic T lymphocytes reach strikingly high levels in people who live beyond 110, revealing an unusual pattern of clonal expansion and functional flexibility, according to a study published in the journal Cell Reports. Researchers characterising these immune cells found that supercentenarians maintain immune profiles that exhibit advanced differentiation without the typical markers of cellular exhaustion, offering new clues into mechanisms of healthy aging and tumor suppression.
CD4 CTL Abundance Across the Human Lifespan
According to single-cell profiling data from the study, CD4 cytotoxic T lymphocytes become increasingly abundant across older age groups. Researchers analyzed 43,584 T cells from eight individuals aged 70 to 90 years, 10 centenarians, and 10 supercentenarians, stratifying them into 13 clusters. The median proportion of CD4 CTLs stood at 4% in non-centenarians, rose to 9.6% in centenarians, and reached 17.6% in supercentenarians. Model-based analysis of public datasets covering more than 1,500 samples across the human lifespan confirmed that these cells remain uncommon at younger ages before expanding markedly in extreme old age.
Did you know? Supercentenarians are individuals who have attained the age of 110 or older. They serve as a biological model for healthy aging because they typically delay or avoid major age-related diseases such as cardiovascular disease and cancer.
Phenotype and Differentiation of CD4 CTLs
The research team investigated the transition of CD4 helper cells toward a cytotoxic phenotype and found distinct surface marker changes. CD4 CTLs are marked by the loss of CD27 and CD28, alongside a characteristic profile of CD45RO+, CD45RA−, CCR7−, PD-1−, and CD95mid. This specific combination indicates advanced cellular differentiation without signs of exhaustion. Transcriptional analysis supported this finding by showing low expression of exhaustion-associated genes, including LAG3 and CTLA4. Furthermore, scientists identified a CD27−CD28+ population comprising 10.5% of CD4 T cells, suggesting a potential transitional state between standard helper cells and fully developed CTLs.
Clonal Expansion and TCR Repertoire Analysis
Clonal expansion of CD4 CTLs appeared across all samples examined by the study authors. Dual TCR expression—meaning the presence of two alpha or beta chains inside a single T cell—turned up in five top clones, though the functional significance of this trait remains uncertain. When analyzing complementary-determining region 3 beta (CDR3β) sequences from top clones, researchers found matches with T cells previously expanded in non-small cell lung cancer, breast cancer, and hepatocellular carcinoma samples from public databases. However, the study authors caution that these matches rely on CDR3β sequences alone and do not establish that the T cells recognize the same identical antigens.
| Age Group | Median CD4 CTL Proportion | Key Cellular Markers |
|---|---|---|
| Non-Centenarians (70–90 years) | 4.0% | Standard helper phenotype, higher CD27/CD28 expression |
| Centenarians (100+ years) | 9.6% | Emerging loss of CD27 and CD28 |
| Supercentenarians (110+ years) | 17.6% | Advanced differentiation, CD45RO+, CCR7−, PD-1− |
Functional Flexibility and Cytokine Profiles
Secondary single-cell analysis using both unstimulated controls and ex vivo stimulation with PMA and ionomycin provided deeper insight into cell function. Activated cells showed upregulated perforin 1 (PRF1) and GZMB, alongside downregulated GZMH and GZMA. These activated cells elevated their expression of inflammatory cytokines tumor necrosis factor-alpha (TNF-α) and interferon-gamma (IFN-γ). Subclustering analysis revealed that highly expanded TCR clones distribute across multiple cytokine-defined subgroups, indicating that cells within the exact same clone can adopt distinct cytokine profiles following activation. Despite these functional insights, the authors emphasize that the study did not directly establish these cells’ functions in vivo, focused on circulating rather than tissue-resident cells, and utilized a relatively small cohort.
Frequently Asked Questions
What are CD4 cytotoxic T lymphocytes?
CD4 cytotoxic T lymphocytes (CD4 CTLs) are rare immune cells that typically appear during viral infections or certain cancers, where they help kill tumor cells. In normal peripheral blood, they are scarce.
Why are supercentenarians studied for immune aging?
Supercentenarians—people aged 110 or older—represent a model of healthy aging because they attain extreme longevity while delaying or entirely avoiding age-related diseases like cardiovascular disease and cancer.
Do CD4 CTLs show signs of exhaustion in supercentenarians?
No. According to the published study, CD4 CTLs in supercentenarians exhibit advanced differentiation without expressing genes associated with cellular exhaustion, such as LAG3 and CTLA4.
Are these immune cells exclusively beneficial?
Researchers note that CD4 CTL accumulation has also been linked to inflammatory and autoimmune pathology in other settings, suggesting these cells may act as a double-edged sword during the aging process.
Stay Updated on Longevity Research
Explore more articles on cellular aging, immunology, and the latest peer-reviewed scientific studies. Subscribe to our newsletter for regular research updates.
Worth a look